NBAS p.Pro593Ser
c.1777C>T · rs1327090386 · VCV1490451
Computational evidence
| Protein change | ||
| AlphaMissense | 0.8247 | likely pathogenic · top 10% in NBAS |
|---|---|---|
| REVEL | 0.36 | indeterminate |
| SaProt | LLR -2.94 | tolerated |
| ⇒ AlphaMissense calls this damaging; SaProt does not; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 1.9, phastCons 1 |
| Regional constraint | o/e 1.03 | unconstrained · MANE · 394 kb · p 0.09 · regional, not allelic |
| Overall | ||
| CADD | 26.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,484 |
| European (non-Finnish)grpmax | 0.00136% | 73,747 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- NBAS
- Protein
- p.Pro593Ser
- Coding
- c.1777C>T
- MANE Select
- NM_015909
- dbSNP
- rs1327090386
- Type
- single nucleotide variant
- Location
- chr2:15468482 (GRCh38)
- Gene constraint
- LOEUF 0.761 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 74.42
- Residue 593
- a UniProt-annotated variant site (in ilfs2; uncertain significance); a UniProt-annotated variant site (found in a patient with a multisystem disease involving liver, eye, immune system, connective tissue and bone; uncertain significance); the 'interaction with use1' region
Similar variants
- NBAS p.Ala1568Val Uncertain significance ★★ ⚠ same condition
- NBAS p.Ala1645Val Uncertain significance ★★ ⚠ same condition
- NBAS p.Ala1795Val Uncertain significance ★★ ⚠ same condition
- NBAS p.Ala1941Gly Uncertain significance ★★ ⚠ same condition
- NBAS p.Ala195Thr Uncertain significance ★★ ⚠ same condition
- NBAS p.Ala2005Thr Uncertain significance ★★ ⚠ same condition
- NBAS p.Ala2341Val Uncertain significance ★★ ⚠ same condition
- NBAS p.Ala48Ser Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nbas-p-pro593ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown